-
Disparities in Breast Cancer Outcomes for Black Women Despite Similar Recurrence ScoresBlack breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
by Eric Fitzsimmons
-
A ‘Revolution’ in Cancer ResearchAACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
by Thomas Celona
-
Finding Your NicheSupport groups offer community for people with cancer in a world that doesn’t understand their experience.
by Carly Flumer
-
Making Informed Consent AccessibleConfusing informed consent forms are a common barrier to clinical trial participation. Researchers ask how they can be better designed for patients.
by Sandra Gordon
-
Keep That Colonoscopy AppointmentExperts weigh in on a recent study appearing to show that colonoscopy had lower-than-expected efficacy for preventing colorectal cancer.
by Pamela Rafalow Grossman
-
What We Know About Ultraprocessed Foods and Cancer RiskResearch has linked highly processed foods like deli meat to a higher risk of colorectal cancer in men.
by Jon Kelvey
-
Patient and Doctor PartnershipsAs more cancer patients take an interest in the science of their care, it’s vital to establish good relationships with doctors.
by Karon Warren
-
Exploring a New FrontierAACR patient advocate forum addresses developments in cancer early detection tests.
by Thomas Celona
-
Forward Look
A New Breast Cancer SubtypeClinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
by Kris Conner
-
Cancer and AlcoholLowering and increasing alcohol consumption is associated with changes in cancer risk.
by Teresa Bergen
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
